The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...
Cigna (CI) and UnitedHealth (UNH) significantly marked up prices for specialty generic drugs over a six-year period.
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
Major health insurers Cigna (CI), UnitedHealth Group (UNH), and CVS Health (CVS) saw their stock prices drop following this statement in Tuesday's session, but appear to be recovering in ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...